World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

PNT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 16.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

POINT Biopharma Global Insider Trading History Chart

POINT Biopharma Global Share Price & Price History

^$12.50

▲ +0.02 (0.16%)

As of 12/27/2023 09:00 PM ET

Mysterious Gold Leverage Just Announced

From Stansberry Research | Ad

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.

POINT Biopharma Global Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/29/2022	Joe A Mccann	CEO	Buy	2,160	$6.64	$14,342.40	3,616,313
11/21/2022	Yael Margolin	Director	Buy	1,710	$6.56	$11,217.60	1,710
11/18/2022	Jonathan R Goodman	Director	Buy	6,000	$6.33	$37,980.00	41,872
11/17/2022	Allan C Silber	Chairman	Buy	27,603	$6.00	$165,618.00	4,246,208
5/25/2022	Neil E Fleshner	Insider	Sell	564,204	$7.51	$4,237,172.04	3,023,045

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for POINT Biopharma Global (NASDAQ:PNT)

59.53% of POINT Biopharma Global stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

POINT Biopharma Global Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/18/2023	Vanguard Group Inc.	4,667,786	$31.13M	0.0%	+4.8%	4.380%
12/7/2023	Hudson Bay Capital Management LP	36,066	$0.24M	0.0%	N/A	0.034%
12/6/2023	Citigroup Inc.	99,775	$0.67M	0.0%	+21.9%	0.094%
11/30/2023	American Century Companies Inc.	794,611	$5.30M	0.0%	+109.9%	0.746%
11/15/2023	Alps Advisors Inc.	78,042	$0.52M	0.0%	-2.7%	0.074%
11/14/2023	Profund Advisors LLC	38,551	$0.26M	0.0%	+5.5%	0.036%
11/13/2023	Portland Investment Counsel Inc.	20,000	$0.13M	0.1%	-82.3%	0.019%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	213,865	$1.43M	0.0%	-20.9%	0.202%
11/13/2023	Federated Hermes Inc.	547,433	$3.65M	0.0%	-3.2%	0.518%
11/13/2023	WINTON GROUP Ltd	16,056	$0.11M	0.0%	N/A	0.015%
11/13/2023	Rafferty Asset Management LLC	223,080	$1.49M	0.0%	+14.0%	0.211%
11/13/2023	DekaBank Deutsche Girozentrale	9,092	$61K	0.0%	N/A	0.009%
11/13/2023	E Fund Management Co. Ltd.	11,463	$76K	0.0%	+8.9%	0.011%
11/9/2023	Citigroup Inc.	99,775	$0.67M	0.0%	+21.9%	0.094%
11/9/2023	Blair William & Co. IL	250,528	$1.67M	0.0%	-5.6%	0.237%
11/9/2023	Jupiter Asset Management Ltd.	524,079	$3.50M	0.0%	+65.4%	0.495%
11/8/2023	Charles Schwab Investment Management Inc.	689,179	$4.60M	0.0%	+184.5%	0.652%
11/8/2023	Swiss National Bank	139,366	$0.93M	0.0%	+1.8%	0.132%
11/7/2023	Virtus ETF Advisers LLC	9,954	$66K	0.0%	-9.0%	0.009%
11/7/2023	Barclays PLC	142,257	$0.95M	0.0%	+23.5%	0.134%
11/2/2023	Principal Financial Group Inc.	30,000	$0.20M	0.0%	+17.8%	0.028%
10/31/2023	Teacher Retirement System of Texas	18,016	$0.12M	0.0%	+4.7%	0.017%
10/27/2023	Allspring Global Investments Holdings LLC	77,736	$0.52M	0.0%	-33.0%	0.073%
10/26/2023	Strs Ohio	83,100	$0.55M	0.0%	+17.0%	0.079%
10/24/2023	Bank of New York Mellon Corp	332,610	$2.22M	0.0%	+1.1%	0.314%
10/24/2023	GW Henssler & Associates Ltd.	24,056	$0.16M	0.0%	N/A	0.023%
9/21/2023	Barclays PLC	115,227	$1.04M	0.0%	+14.1%	0.109%
8/25/2023	Yarbrough Capital LLC	42,130	$0.38M	0.0%	N/A	0.040%
8/15/2023	Silverarc Capital Management LLC	93,700	$0.85M	0.3%	-52.8%	0.089%
8/15/2023	Beutel Goodman & Co Ltd.	7,174	$64K	0.0%	N/A	0.007%
8/15/2023	Capula Management Ltd	57,140	$0.52M	0.0%	N/A	0.054%
8/14/2023	Great Point Partners LLC	3,000,000	$27.18M	5.3%	-11.3%	2.839%
8/14/2023	Bellevue Group AG	1,256,197	$11.38M	0.2%	N/A	1.189%
8/14/2023	Deep Track Capital LP	2,781,565	$25.20M	1.2%	+18.6%	2.630%
8/14/2023	Thrivent Financial for Lutherans	961,515	$8.71M	0.0%	N/A	0.910%
8/14/2023	Eagle Health Investments LP	306,142	$2.77M	0.5%	N/A	0.290%
8/14/2023	Graham Capital Management L.P.	19,533	$0.18M	0.0%	-86.5%	0.018%
8/11/2023	Westwood Holdings Group Inc.	12,420	$0.11M	0.0%	N/A	0.012%
8/11/2023	Rubric Capital Management LP	190,000	$1.72M	0.1%	-92.8%	0.180%
8/11/2023	Velan Capital Investment Management LP	342,936	$3.11M	2.9%	-30.6%	0.325%
8/11/2023	E Fund Management Co. Ltd.	10,524	$95K	0.0%	N/A	0.010%
8/10/2023	Profund Advisors LLC	36,555	$0.33M	0.0%	+11.8%	0.035%
8/10/2023	Jupiter Asset Management Ltd.	316,802	$2.86M	0.0%	+263.7%	0.300%
8/10/2023	US Bancorp DE	15,710	$0.14M	0.0%	N/A	0.015%
8/8/2023	Fisher Asset Management LLC	99,189	$0.90M	0.0%	-16.6%	0.094%
8/8/2023	AlphaCentric Advisors LLC	70,000	$0.63M	0.4%	N/A	0.066%
8/4/2023	American International Group Inc.	43,553	$0.40M	0.0%	+4.0%	0.041%
8/3/2023	Barclays PLC	115,227	$1.04M	0.0%	+14.1%	0.109%
8/3/2023	Scotia Capital Inc.	50,000	$0.45M	0.0%	-86.7%	0.047%
8/3/2023	Bank of New York Mellon Corp	329,015	$2.98M	0.0%	+32.3%	0.311%
8/1/2023	Firethorn Wealth Partners LLC	22,405	$0.20M	0.2%	-18.2%	0.021%
7/31/2023	Strs Ohio	71,000	$0.64M	0.0%	N/A	0.067%
7/28/2023	First Republic Investment Management Inc.	20,000	$0.18M	0.0%	+33.3%	0.019%
7/28/2023	Moody Aldrich Partners LLC	145,442	$1.32M	0.3%	N/A	0.138%
7/24/2023	Allspring Global Investments Holdings LLC	116,053	$1.05M	0.0%	+107.7%	0.110%
7/24/2023	Vontobel Holding Ltd.	12,000	$0.11M	0.0%	-93.8%	0.011%
7/21/2023	Clear Harbor Asset Management LLC	10,000	$91K	0.0%	N/A	0.009%
7/20/2023	Exchange Traded Concepts LLC	14,102	$0.13M	0.0%	N/A	0.013%
7/19/2023	Teacher Retirement System of Texas	17,202	$0.16M	0.0%	-11.9%	0.016%
7/18/2023	Allspring Global Investments Holdings LLC	116,053	$1.05M	0.0%	+107.7%	0.110%
7/13/2023	Yarbrough Capital LLC	42,130	$0.38M	0.0%	N/A	0.040%
5/16/2023	Great Point Partners LLC	3,383,029	$24.60M	4.8%	+33.1%	3.201%
5/16/2023	BVF Inc. IL	10,563,748	$76.80M	2.8%	+15.1%	9.996%
5/15/2023	Affinity Asset Advisors LLC	149,586	$1.09M	0.4%	-50.7%	0.142%
5/15/2023	Rubric Capital Management LP	2,645,336	$19.23M	0.5%	+44.8%	2.503%
5/12/2023	Sectoral Asset Management Inc.	182,668	$1.33M	0.3%	-1.4%	0.173%
5/12/2023	Martingale Asset Management L P	85,410	$0.62M	0.0%	N/A	0.081%
5/12/2023	Profund Advisors LLC	32,709	$0.24M	0.0%	N/A	0.031%
5/10/2023	Pier Capital LLC	862,736	$6.27M	1.0%	N/A	0.816%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	66,657	$0.49M	0.0%	N/A	0.063%
5/10/2023	Jupiter Asset Management Ltd.	87,115	$0.63M	0.0%	N/A	0.082%
5/4/2023	Barclays PLC	100,958	$0.74M	0.0%	-43.4%	0.096%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	63,971	$0.47M	0.0%	+108.3%	0.061%
5/2/2023	Firethorn Wealth Partners LLC	27,380	$0.21M	0.2%	-23.7%	0.026%
5/2/2023	Amalgamated Bank	12,014	$87K	0.0%	-18.2%	0.011%
4/14/2023	Raymond James Financial Services Advisors Inc.	13,500	$98K	0.0%	N/A	0.013%
4/13/2023	Allspring Global Investments Holdings LLC	55,888	$0.41M	0.0%	-8.8%	0.053%
4/12/2023	Vontobel Holding Ltd.	194,668	$1.42M	0.0%	-1.3%	0.184%
3/23/2023	MetLife Investment Management LLC	46,389	$0.34M	0.0%	+13.3%	0.045%
3/13/2023	Claro Advisors LLC	11,820	$86K	0.0%	-25.8%	0.011%
2/15/2023	Avidity Partners Management LP	2,432,400	$17.73M	0.4%	-13.7%	2.338%
2/15/2023	Nantahala Capital Management LLC	572,191	$4.17M	0.3%	+189.3%	0.550%
2/10/2023	Sectoral Asset Management Inc.	185,278	$1.35M	0.3%	N/A	0.178%
2/10/2023	Cheyne Capital Management UK LLP	127,090	$0.93M	1.6%	N/A	0.122%
2/9/2023	Principal Financial Group Inc.	26,708	$0.20M	0.0%	+152.0%	0.026%
2/9/2023	Citigroup Inc.	131,276	$0.96M	0.0%	-6.1%	0.126%
2/8/2023	Swiss National Bank	150,766	$1.10M	0.0%	-5.4%	0.145%
2/8/2023	Arizona State Retirement System	17,613	$0.13M	0.0%	+59.8%	0.017%
2/2/2023	SG Americas Securities LLC	29,744	$0.22M	0.0%	+31.2%	0.029%
2/2/2023	ProShare Advisors LLC	10,999	$80K	0.0%	N/A	0.011%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	11,114	$81K	0.0%	+31.0%	0.011%
11/15/2022	Perceptive Advisors LLC	500,000	$3.87M	0.1%	-53.4%	0.481%
11/15/2022	PFM Health Sciences LP	4,515,216	$34.90M	1.3%	N/A	4.341%
11/15/2022	Polar Asset Management Partners Inc.	350,900	$2.71M	0.0%	+72.9%	0.337%
11/15/2022	BVF Inc. IL	5,590,048	$43.21M	1.8%	+66.0%	5.373%
11/15/2022	Bayesian Capital Management LP	14,962	$0.12M	0.0%	N/A	0.014%
11/15/2022	Citadel Advisors LLC	3,679,997	$28.45M	0.0%	+59.3%	3.537%
11/14/2022	Tudor Investment Corp Et Al	10,282	$79K	0.0%	N/A	0.010%
11/14/2022	Point72 Asset Management L.P.	3,692,620	$28.54M	0.1%	+89.0%	3.550%
11/14/2022	Cubist Systematic Strategies LLC	88,084	$0.68M	0.0%	+5,405.3%	0.085%

Data available starting January 2016

POINT Biopharma Global Inc., a radiopharmaceutical company, develops and commercializes radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast activation protein-alpha inhibitor targeting program being developed for use in various tumor types that is under preclinical studies. In addition, it has product candidates being developed on CanSEEK technology sub-licensed from both Bach Biosciences LLC and Avacta Life Sciences Limited. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana.

Today's Range

Now: $12.50

$12.49

$12.51

50 Day Range

MA: $12.98

$12.45

$14.23

52 Week Range

Now: $12.50

$6.57

$14.35

Volume

3,290,900 shs

Average Volume

1,442,213 shs

Market Capitalization

$1.33 billion

P/E Ratio

13.89

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of POINT Biopharma Global?: POINT Biopharma Global's top insider shareholders include:
Allan C Silber (Chairman)
Joe A Mccann (CEO)
Neil E Fleshner (Insider)
Jonathan R Goodman (Director)
Yael Margolin (Director)
Bvf Partners L P/Il (Major Shareholder)
Learn More about top insider investors at POINT Biopharma Global.